VAXZEVRIA/COVID-19 Vaccine AstraZeneca - Important Safety Information from AstraZeneca (Ireland) DAC as approved by the HPRA (13.10.21)

Notice type: 3rd Party Publications

Date: 15/10/2021

Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC regarding VAXZEVRIA/COVID-19 Vaccine AstraZeneca: Risk of thrombocytopenia (including immune thrombocytopenia) with or without associated bleeding